ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01767792
Recruitment Status : Active, not recruiting
First Posted : January 14, 2013
Last Update Posted : May 4, 2017
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Bruce Korf, MD, University of Alabama at Birmingham

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2019